{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:42Z","timestamp":1791281742474,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41366-021-00935-x","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T16:04:08Z","timestamp":1629129848000},"page":"2562-2569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Weight gain and obesity rates in transgender and gender-diverse adults before and during hormone therapy"],"prefix":"10.1038","volume":"45","author":[{"given":"M.","family":"Kyinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Leemaqz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sarkodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-1941","authenticated-orcid":false,"given":"M. S.","family":"Irwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"935_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","volume":"5","author":"MS Irwig","year":"2017","unstructured":"Irwig MS. Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 2017;5:301\u201311.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"935_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","volume":"5","author":"V Tangpricha","year":"2017","unstructured":"Tangpricha V, den Heijer M. Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol. 2017;5:291\u2013300.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"935_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","volume":"366","author":"DW Haslam","year":"2005","unstructured":"Haslam DW, James WP. Obesity. Lancet. 2005;366:1197\u2013209.","journal-title":"Lancet."},{"key":"935_CR4","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jamainternmed.2017.1460","volume":"177","author":"CG Streed Jr","year":"2017","unstructured":"Streed CG Jr, McCarthy EP, Haas JS. Association between gender minority status and self-reported physical and mental health in the United States. JAMA Intern Med. 2017;177:1210\u20132.","journal-title":"JAMA Intern Med."},{"key":"935_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/lgbt.2016.0208","volume":"4","author":"CN Dragon","year":"2017","unstructured":"Dragon CN, Guerino P, Ewald E, Laffan AM. Transgender medicare beneficiaries and chronic conditions: exploring fee-for-service claims data. LGBT Health. 2017;4:404\u201311.","journal-title":"LGBT Health."},{"key":"935_CR6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1210\/jc.2018-02138","volume":"104","author":"DM van Velzen","year":"2019","unstructured":"van Velzen DM, Paldino A, Klaver M, Nota NM, Defreyne J, Hovingh GK, et al. Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen. J Clin Endocrinol Metab. 2019;104:1937\u201347.","journal-title":"J Clin Endocrinol Metab."},{"key":"935_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","volume":"125","author":"MB Deutsch","year":"2015","unstructured":"Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125:605\u201310.","journal-title":"Obstet Gynecol"},{"key":"935_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","volume":"58","author":"JM Elbers","year":"2003","unstructured":"Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol. 2003;58:562\u201371.","journal-title":"Clin Endocrinol."},{"key":"935_CR9","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2016-1276","volume":"101","author":"AD Fisher","year":"2016","unstructured":"Fisher AD, Castellini G, Ristori J, Casale H, Cassioli E, Sensi C, et al. Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Clin Endocrinol Metab. 2016;101:4260\u20139.","journal-title":"J Clin Endocrinol Metab."},{"key":"935_CR10","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/jsm.12698","volume":"11","author":"C Pelusi","year":"2014","unstructured":"Pelusi C, Costantino A, Martelli V, Lambertini M, Bazzocchi A, Ponti F, et al. Effects of three different testosterone formulations in female-to-male transsexual persons. J Sex Med. 2014;11:3002\u201311.","journal-title":"J Sex Med."},{"key":"935_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.endonu.2015.02.001","volume":"62","author":"C Quiros","year":"2015","unstructured":"Quiros C, Patrascioiu I, Mora M, Aranda GB, Hanzu FA, G\u00f3mez-Gil E, et al. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. experience in a specialized unit in catalonia. Endocrinol Nutr. 2015;62:210\u20136.","journal-title":"Endocrinol Nutr."},{"key":"935_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-14-0586","volume":"172","author":"E Van Caenegem","year":"2015","unstructured":"Van Caenegem E, Wierckx K, Taes Y, Schreiner T, Vandewalle S, Toye K, et al. Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). Eur J Endocrinol. 2015;172:163\u201371.","journal-title":"Eur J Endocrinol."},{"key":"935_CR13","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: Results from the european network for the investigation of gender incongruence. J Sex Med. 2014;11:1999\u20132011.","journal-title":"J Sex Med."},{"key":"935_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0030-1255074","volume":"119","author":"A Mueller","year":"2011","unstructured":"Mueller A, Zollver H, Kronawitter D, Oppelt PG, Claassen T, Hoffmann I, et al. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Exp Clin Endocrinol Diabetes. 2011;119:95\u2013100.","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"935_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, Machler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. Journal of Statistical Software. 2015;67:1\u201348.","journal-title":"Journal of Statistical Software"},{"key":"935_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1677\/joe.0.1800107","volume":"180","author":"EJ Giltay","year":"2004","unstructured":"Giltay EJ, Toorians AW, Sarabdjitsingh AR, de Vries NA, Gooren LJ. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol. 2004;180:107\u201312.","journal-title":"J Endocrinol."},{"key":"935_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-17-0496","volume":"178","author":"M Klaver","year":"2018","unstructured":"Klaver M, de Blok CJM, Wiepjes CM, Nota NM, Dekker MJHJ, de Mutsert R, et al. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Eur J Endocrinol. 2018;178:163\u201371.","journal-title":"Eur J Endocrinol."},{"key":"935_CR18","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","volume":"7","author":"A Mueller","year":"2010","unstructured":"Mueller A, Haeberle L, Zollver H, Claassen T, Kronawitter D, Oppelt PG, et al. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. J Sex Med. 2010;7:3190\u20138.","journal-title":"J Sex Med."},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.jcte.2020.100230","volume":"21","author":"P Suppakitjanusant","year":"2020","unstructured":"Suppakitjanusant P, Ji Y, Stevenson MO, Chantrapanichkul P, Sineath RC, Goodman M, et al. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study. J Clin Transl Endocrinol. 2020;21:100230 https:\/\/doi.org\/10.1016\/j.jcte.2020.100230. eCollection 2020","journal-title":"J Clin Transl Endocrinol."},{"key":"935_CR20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1447-0756.2008.00857.x","volume":"34","author":"Y Emi","year":"2008","unstructured":"Emi Y, Adachi M, Sasaki A, Nakamura Y, Nakatsuka M. Increased arterial stiffness in female-to-male transsexuals treated with androgen. J Obstet Gynaecol Res. 2008;34:890\u20137.","journal-title":"J Obstet Gynaecol Res."},{"key":"935_CR21","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief. 2020;1-8."},{"key":"935_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jadohealth.2016.08.027","volume":"60","author":"CE Guss","year":"2017","unstructured":"Guss CE, Williams DN, Reisner SL, Austin SB, Katz-Wise SL. Disordered Weight Management Behaviors, Nonprescription Steroid Use, and Weight Perception in Transgender Youth. J Adolesc Health. 2017;60:17\u201322.","journal-title":"J Adolesc Health."}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00935-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:05:00Z","timestamp":1637539500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-00935-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1038\/s41366-021-00935-x","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}